The Journal of Immunology, Vol 150, Issue 10 4524-4531, Copyright © 1993 by American Association of Immunologists

ARTICLES

Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide

MJ Herriott, H Jiang, CA Stewart, DJ Fast and RW Leu
Oklahoma Medical Research Foundation, Noble Center for Biomedical Research, Oklahoma City 73104.

Previously we found that murine macrophage migration inhibition (MMI) was mediated by IFN-gamma-priming and lipid A triggering. With the recent availability of human recombinant migration inhibitory factor (MIF), which is distinctly different from IFN-gamma and other cytokines, we have now attempted to explore possible mechanistic differences between IFN-gamma and MIF to mediate MMI. Neither MIF not IFN-gamma were active alone, but effectively primed murine inflammatory macrophages for subsequent triggering by lipid A to mediate MMI. A specific neutralizing antibody for rMIF abrogated MMI mediated only by MIF and not by IFN-gamma-primed macrophages. Distinct differences were also found between the mechanisms by which MIF and IFN-gamma synergized with lipid A for activation in that IFN-gamma-primed and lipid A triggered macrophages produced TNF and nitric oxide (NO), whereas MIF- primed cells did not. Macrophages primed with IFN-gamma and triggered by rTNF were inhibited in their migration, whereas MIF failed to synergize with rTNF for MMI. An inhibitor of NO production NG- monomethyl-L-arginine inhibited MMI mediated by higher activating concentrations of lipid A and by IFN-gamma-primed and lipid A triggered macrophages, but had no effect on MIF-primed cells in concert with lipid A for increased expression of both TNF-alpha mRNA and NO synthase mRNA. Taken together, our results indicate that both MIF and IFN-gamma prime macrophages to synergize with lipid A to mediate MMI but by different mechanisms. The activation process by IFN-gamma to mediate migration inhibition appears to resemble requirements for rendering macrophages tumor cytotoxic in the production of TNF for autocrine- mediated NO generation by primed macrophages. In contrast, MIF-mediated MMI was independent of requirements for either TNF or NO production.

This article has been cited by other articles:

				E. A. V. Ferro, J. R. Mineo, F. Ietta, N. Bechi, R. Romagnoli, D. A. O. Silva, G. Sorda, E. Bevilacqua, and L. R. Paulesu Macrophage Migration Inhibitory Factor Is Up-Regulated in Human First-Trimester Placenta Stimulated by Soluble Antigen of Toxoplasma gondii, Resulting in Increased Monocyte Adhesion on Villous Explants Am. J. Pathol., January 1, 2008; 172(1): 50 - 58. [Abstract] [Full Text] [PDF]

				A. P. Kohm, Y. Tang2, V. M. Sanders, and S. B. Jones3 Activation of Antigen-Specific CD4+ Th2 Cells and B Cells In Vivo Increases Norepinephrine Release in the Spleen and Bone Marrow J. Immunol., July 15, 2000; 165(2): 725 - 733. [Abstract] [Full Text] [PDF]

				T. Tomura, H. Watarai, N. Honma, M. Sato, A. Iwamatsu, Y. Kato, R. Kuroki, T. Nakano, T. Mikayama, and K. Ishizaka Immunosuppressive Activities of Recombinant Glycosylation -Inhibiting Factor Mutants J. Immunol., January 1, 1999; 162(1): 195 - 202. [Abstract] [Full Text] [PDF]

				K. Sugie, T. Nakano, T. Tomura, K. Takakura, T. Mikayama, and K. Ishizaka High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells PNAS, May 13, 1997; 94(10): 5278 - 5283. [Abstract] [Full Text] [PDF]

				H. Y. Lan, M. Bacher, N. Yang, W. Mu, D. J. Nikolic-Paterson, C. Metz, A. Meinhardt, R. Bucala, and R. C. Atkins The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat J. Exp. Med., April 21, 1997; 185(8): 1455 - 1466. [Abstract] [Full Text] [PDF]